CNN || Behavior & Cognition

Say goodbye to ‘dementia’

Posted on: 26/03/2014 - 18:50

ORLANDO – This May, the hallowed term "dementia" is supposed to be tossed onto the scrapheap of discarded psychiatric nomenclature, replaced by "major neurocognitive disorder."...

Field of Interest: Geriatrics

Type: News Item

Glycerol phenylbutyrate reduces hepatic encephalopathy events in cirrhosis

Posted on: 10/03/2014 - 15:35

Glycerol phenylbutyrate significantly reduced the number of cirrhosis patients experiencing hepatic encephalopathy and the time to first event, a phase II trial has shown. The randomized,...

Field of Interest: Gastroentero...

Type: News Item

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

Posted on: 03/02/2014 - 21:00

Neither intensive blood pressure control nor intensive lipid management slowed cognitive decline in adults with long-standing type 2 diabetes. Additionally, after 40 months, patients in the ACCORD...

Field of Interest: Endocrinology

Type: News Item

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

Posted on: 03/02/2014 - 21:00

Neither intensive blood pressure control nor intensive lipid management slowed cognitive decline in adults with long-standing type 2 diabetes. Additionally, after 40 months, patients in the ACCORD...

Field of Interest: Geriatrics

Type: News Item

The politics of food addiction: Who wins, who 'loses'

Posted on: 28/01/2014 - 17:15

ATLANTA – It’s too soon to disrupt current obesity treatment by declaring food addiction to be a clinical condition, according to Dr. Paul Fletcher. "If we are to employ [the term] food...

Field of Interest: Endocrinology

Type: News Item

DDT metabolite may be associated with risk for Alzheimer’s

Posted on: 27/01/2014 - 21:00

A metabolite of the pesticide DDT – banned in the United States since 1972 – was associated with late-onset Alzheimer’s disease in a small, case-control study. Levels of the chemical...

Field of Interest: Geriatrics

Type: News Item

Two Alzheimer’s immunotherapy drugs flunk in four studies

Posted on: 22/01/2014 - 22:00

Two investigational Alzheimer’s immunotherapies failed to show any benefit in a series of phase III trials comprising more than 4,000 patients. Neither bapineuzumab, which targets soluble and...

Field of Interest: Geriatrics

Type: News Item

Say goodbye to ‘dementia’

Glycerol phenylbutyrate reduces hepatic encephalopathy events in cirrhosis

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

The politics of food addiction: Who wins, who 'loses'

DDT metabolite may be associated with risk for Alzheimer’s

Two Alzheimer’s immunotherapy drugs flunk in four studies

Newsletters

Latest Newsletters

You are here

CNN || Behavior & Cognition

Say goodbye to ‘dementia’

Glycerol phenylbutyrate reduces hepatic encephalopathy events in cirrhosis

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

Intensive BP, lipid control didn’t alter cognitive decline in type 2 diabetes

The politics of food addiction: Who wins, who 'loses'

DDT metabolite may be associated with risk for Alzheimer’s

Two Alzheimer’s immunotherapy drugs flunk in four studies

Newsletters

Latest Newsletters